Chromatin Bioscience Innovates by Joining JLABS EMEA for Gene Therapy Advancements Chromatin Bioscience is thrilled to announce its membership in JLABS EMEA, enhancing its capacity for innovations in gene therapy technologies and collaborations.

Chromatin Bioscience Innovates by Joining JLABS EMEA for Gene Therapy Advancements #Edinburgh #Scotland #Chromatin_Bioscience #JLABS_EMEA #synthetic_promoters